Pharmacovigilance of quality deviations in the public healthcare system
Drug quality deviation (DQD) is the disagreement with the parameters at the registration with after commercialization step. Pharmacovigilance programs should be notified of DQD to ensure drug efficacy and support patient safety. Objective: To describe DQD from public healthcare system and its impact...
Saved in:
Main Authors: | Carolina Resende Bitencourt (Author), Cristiane Aparecida Menezes De Pádua (Author), Paula Lana De Miranda Drummond (Author), Edson Perini (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacovigilance of thalidomide in the Brazilian Health System and patient safety
by: Paula Lana de Miranda Drummond, et al.
Published: (2021) -
Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015) -
Era of pharmacovigilance: Revolution in healthcare
by: Upendra Nagaich
Published: (2015) -
Drug quality deviations: notifications in a sentinel hospital in Ceará
by: Elana F. CHAVES, et al.
Published: (2020) -
Mıdlıne Devıatıons And Treatments
by: M. Serdar Toroğlu
Published: (2000)